Publications

In vitro activity of oritavancin against streptococci, including macrolide- and/or lincosamide (constitutive)-resistant and MDR isolates from EU hospitals (2010-2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark

View publication